Commercial health plans’ value-pay response to pandemic mixed, say providers
Commercial health plans have offered providers in value-based payments some pandemic-related flexibilities but rejected some changes.
News briefs: Trends in hospital volumes and margins, and other forces shaping healthcare finance
Read about the key factors that shaped healthcare finance policy and practice June and July 2020.
How to develop a winning pricing strategy in the post-COVID-19 consumer market
Providers and health plans should prepare for federally imposed price transparency mandates imposed by developing comprehensive pricing strategies tailored to their specific market positions, financials and operational objectives.
News briefs September 2020: Trends in hospital volumes and margins, and other forces shaping healthcare finance
Read about the key factors that shaped healthcare finance policy and practice in August 2020.
Price transparency as a guiding principle: directionally correct
HFMA President and CEO Joe Fifer offers a perspective on HFMA’s approach to price transparency vis-à-vis the upcoming CMS regulations on payment rate transparency.
Telehealth helped chronically ill during pandemic but their access to care worsened: CDC
Many chronically ill sought telehealth care during the pandemic, even as they reported worse care access, according to a CDC survey.
Cleveland Clinic strikes deal to provide virtual second opinions to Aetna members
HFMA's Chad Mulvany says center of excellence models, similar to those the Cleveland Clinic partners with, select employers that have proven ability to reduce the total cost of care and improve outcomes.
Looking beyond CMS: How to accelerate the transition to value in healthcare
HFMA's Chad Mulvany summarizes a blog on actions CMS and Congress can take to transition providers to capitated and other risk-bearing payment models.
HHS updates COVID-19 payment and reporting requirements
Hospitals will need to meet testing requirements after Sept. 1 to receive future Medicare payment increases for treating COVID-19 patients.
U.S hospitals can no longer afford the burden of administrative waste
Even before the COVID-19 crisis, U.S. healthcare providers faced growing challenges from administrative and regulatory burdens. But the pandemic has these challenges to the point that they mare likely to impose severe financial consequences on providers.